Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.24M+52.7% | -$21.66M-33.4% | -$16.24M-371% | -$3.45M-75.3% | -$1.97M-2.2% | ||
| $469K+37.9% | $340K— | —— | —— | $0— | ||
| $1.91M+6.1% | $1.8M-34.9% | $2.76M+568% | $413.32K-15.0% | $486K-8.3% | ||
| -$13.13M-110% | -$6.25M+59.0% | -$15.26M-3,312% | -$447.27K+29.2% | -$632K+5.7% | ||
| $194K— | —— | —— | —— | $0— | ||
| —— | $690.25K0.0% | $690.25K0.0% | $690.25K0.0% | $690.25K— | ||
| -$194K+97.6% | -$8M— | —— | —— | $0— | ||
| $0— | $0-100% | $68K-81.9% | $375K+50.0% | $250K+86.6% | ||
| $27.52M+52.7% | $18.02M-32.5% | $26.69M+7,018% | $375K+50.0% | $250K— | ||
| $14.2M+277% | $3.77M-73.4% | $14.19M+19,740% | -$72.27K+81.1% | -$382K— | ||
| -$13.32M— | —— | —— | —— | -$632K+56.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
